Cargando…

Variable NF-κB pathway responses in colon cancer cells treated with chemotherapeutic drugs

BACKGROUND: The nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) signaling pathway is activated in cells exposed to various stimuli, including those originating on the cell surface or in the nucleus. Activated NF-κB signaling is thought to enhance cell survival in response to t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Samuel, Temesgen, Fadlalla, Khalda, Gales, Dominique N, Putcha, Balananda DK, Manne, Upender
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4152571/ https://www.ncbi.nlm.nih.gov/pubmed/25134433 http://dx.doi.org/10.1186/1471-2407-14-599

Ejemplares similares

3-(2-Bromoethyl)-indole inhibits the growth of cancer cells and NF-κB activation
por: FADLALLA, KHALDA, et al.
Publicado: (2015)

The Chemokine CXCL8 in Carcinogenesis and Drug Response
por: Gales, Dominique, et al.
Publicado: (2013)

Camptothecin Induces PD-L1 and Immunomodulatory Cytokines in Colon Cancer Cells
por: Bedi, Deepa, et al.
Publicado: (2019)

Clinical Implications of Rabphillin-3A-Like Gene Alterations in Breast Cancer
por: Putcha, Balananda-Dhurjati Kumar, et al.
Publicado: (2015)

Interferon-α sensitizes HBx-expressing hepatocarcinoma cells to chemotherapeutic drugs through inhibition of HBx-mediated NF-κB activation
por: Liu, Yanning, et al.
Publicado: (2013)

Chemotherapeutic Drugs Inhibiting Topoisomerase 1 Activity Impede Cytokine-Induced and NF-κB p65-Regulated Gene Expression
por: Riedlinger, Tabea, et al.
Publicado: (2019)

NF-κB-regulated VentX expression mediates tumoricidal effects of chemotherapeutics at noncytotoxic concentrations
por: Le, Yi, et al.
Publicado: (2022)

Phthalate exposure promotes chemotherapeutic drug resistance in colon cancer cells
por: Chen, Hsin-Pao, et al.
Publicado: (2017)

Prostate apoptosis response protein 4 sensitizes human colon cancer cells to chemotherapeutic 5-FU through mediation of an NFκB and microRNA network
por: Wang, Bi-Dar, et al.
Publicado: (2010)

NF-κB Signaling and Inflammation—Drug Repurposing to Treat Inflammatory Disorders?
por: Roberti, Annabell, et al.
Publicado: (2022)

Colon contradictions: NF-κB signaling in intestinal tumorigenesis
por: Fordham, Robert P., et al.
Publicado: (2015)

Nef-M1, a peptide antagonist of CXCR4, inhibits tumor angiogenesis and epithelial-to-mesenchymal transition in colon and breast cancers
por: Katkoori, Venkat R., et al.
Publicado: (2015)

Sulindac activates NF-κB signaling in colon cancer cells
por: Mladenova, Dessislava, et al.
Publicado: (2013)

Chemotherapeutic Drugs Induce Different Gut Microbiota Disorder Pattern and NOD/RIP2/NF-κB Signaling Pathway Activation That Lead to Different Degrees of Intestinal Injury
por: Huang, Bin, et al.
Publicado: (2022)

Multiphysics and Multiscale Analysis for Chemotherapeutic Drug
por: Zhang, Linan, et al.
Publicado: (2015)

Role of chemotherapeutic drugs in immunomodulation of cancer
por: Mukherjee, Oishi, et al.
Publicado: (2023)

A comparison of 12-gene colon cancer assay gene expression in African American and Caucasian patients with stage II colon cancer
por: Govindarajan, Rangaswamy, et al.
Publicado: (2016)

Drug–Drug Interactions of Cannabidiol with Standard-of-Care Chemotherapeutics
por: Buchtova, Tereza, et al.
Publicado: (2023)

Oncologic Outcomes of Stage IIIA Colon Cancer for Different Chemotherapeutic Regimens
por: Lee, Yoo Sung, et al.
Publicado: (2012)

Ionic Interpretation of Drug Action in Chemotherapeutic Research
Publicado: (1956)

Tumour suppressor genes in chemotherapeutic drug response
por: Lai, Dulcie, et al.
Publicado: (2012)

The effect of chemotherapeutic drugs on human B lymphocytes
por: Zirakzadeh, Ali, et al.
Publicado: (2013)

Local bacteria affect the efficacy of chemotherapeutic drugs
por: Lehouritis, Panos, et al.
Publicado: (2015)

Chemotherapeutic Drugs: DNA Damage and Repair in Glioblastoma
por: Annovazzi, Laura, et al.
Publicado: (2017)

Advances in Cancer Chemotherapeutic Drug Research in China
por: Xu, Bin, et al.
Publicado: (2012)

Research progress of anti-glioma chemotherapeutic drugs
por: Zhou, Yi-Shu, et al.
Publicado: (2022)

The chemotherapeutic drug methotrexate selects for antibiotic resistance
por: Guðmundsdóttir, Jónína S., et al.
Publicado: (2021)

Plica Polonica Secondary to Chemotherapeutic Drugs Combination
por: Pangti, Rashi, et al.
Publicado: (2023)

ZHX2 enhances the cytotoxicity of chemotherapeutic drugs in liver tumor cells by repressing MDR1 via interfering with NF-YA
por: Ma, Hongxin, et al.
Publicado: (2014)

Advances in pancreatic cancer biomarkers
por: Hasan, Syed, et al.
Publicado: (2019)

Comparative transcriptome analyses reveal genes associated with SARS-CoV-2 infection of human lung epithelial cells
por: Chandrashekar, Darshan S., et al.
Publicado: (2021)

Genistein improves inflammatory response and colonic function through NF-κB signal in DSS-induced colonic injury
por: Zhang, Rui, et al.
Publicado: (2017)

Colonic Epithelial PHLPP2 Deficiency Promotes Colonic Epithelial Pyroptosis by Activating the NF-κB Signaling Pathway
por: Li, De-feng, et al.
Publicado: (2021)

Sources of dynamic variability in NF-κB signal transduction: A mechanistic model
por: Mothes, Janina, et al.
Publicado: (2015)

Prognostic value of loss of heterozygosity and sub-cellular localization of SMAD4 varies with tumor stage in colorectal cancer
por: Jia, Xu, et al.
Publicado: (2017)

Inhibition of IRES-dependent translation of caspase-2 by HuR confers chemotherapeutic drug resistance in colon carcinoma cells
por: Badawi, Amel, et al.
Publicado: (2018)

Engineered exosomes for targeted co-delivery of miR-21 inhibitor and chemotherapeutics to reverse drug resistance in colon cancer
por: Liang, Gaofeng, et al.
Publicado: (2020)

Apigenin inhibits colonic inflammation and tumorigenesis by suppressing STAT3-NF-κB signaling
por: Ai, Xiao-Yu, et al.
Publicado: (2017)

Delivery of chemotherapeutic agents using drug-loaded irradiated tumor cells to treat murine ovarian tumors
por: Kim, Daejin, et al.
Publicado: (2010)

NF-κB downstream miR-1262 disturbs colon cancer cell malignant behaviors by targeting FGFR1: NF-κB/miR-1262/FGFR1 modulates colon cancer oncogenesis
por: Zhang, Weilin, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_vhogvlkaur34k5019n416chr90